ISSN: 2631-3278
Drugs play predominant role in human daily life and have a greater impact as well. As we witnessed many terrific diseases, it is important to design and develop new drugs on a regular basis and should be delivered safely to the targete...
Explore the journal aims, scope and subject coverage before submission.
View editorial leadership and board information for this journal.
Browse current research articles and article updates from this journal.
Open Access publishing information is available for authors and readers.
Francisco Foubelo was born in Carreña-Cabrales (Asturias) in 1961. He studied chemistry at the University of Oviedo from which he received B.S. (1984), M.S. (1986), and Ph.D. (1989) degrees. After a postdoctoral stay (1989–1991) as a Fulbright fellow at Princeton University in the group of Professor Martin F. Semmelhack, he moved to the University of Alicante and joined the research group of Professor Miguel Yus where he became Associate Professor in 1995 and Full in 2002. Now he is a member of the Department of Organic Chemistry and the Organic Synthesis Institute (ISO) at this University. He has published more than 140 papers and is cofounder of the new chemical company MEDALCHEMY, S.L. as a spin-off of the University of Alicante. His research interest are focused on the development of new synthetic methodologies for asymmetric synthesis related to chiral sulfinimines, hetero functionalization of alkenes and alkynes, and stereoselective synthesis of nitrogen-containing heterocycles, such as natural alkaloids and related biologically active compounds.
Discover peer-reviewed open access journals across diverse disciplines.